The rise in metastatic prostate cancer incidence, predicted by opponents of the 2012 US move away from routine PSA screening…
Read more
Complementary and alternative therapies may not be evidence-based treatment for prostate cancer, but many patients may think…
Read more
Nearly three-quarters of Australian men with low-risk prostate cancer are not being followed-up in line with best practice,…
Read more
Most men diagnosed with low-risk prostate cancer are slipping through the cracks, Australian research shows. A study by…
Read more
Results from a large meta-analysis support the RACGP’s view that routine digital rectal examination (DRE) for prostate…
Read more
Men should not be dissuaded from having PSA tests just because the latest evidence suggests they may do more harm than good,…
Read more
The largest prostate cancer screening study to date has found that a one-off test detects more early-stage, low-grade…
Read more